View Future GrowthIMCD 過去の業績過去 基準チェック /26IMCDは、平均年間8.1%の収益成長を遂げていますが、 Trade Distributors業界の収益は、年間 成長しています。収益は、平均年間7.3% 9.4%収益成長率で 成長しています。 IMCDの自己資本利益率は10.7%であり、純利益率は4.5%です。主要情報8.07%収益成長率7.29%EPS成長率Trade Distributors 業界の成長23.44%収益成長率9.44%株主資本利益率10.65%ネット・マージン4.53%次回の業績アップデート29 Jul 2026最近の業績更新お知らせ • May 06IMCD N.V. to Report Q1, 2027 Results on Apr 29, 2027IMCD N.V. announced that they will report Q1, 2027 results on Apr 29, 2027お知らせ • Apr 17+ 3 more updatesIMCD N.V. to Report Nine Months, 2027 Results on Nov 04, 2027IMCD N.V. announced that they will report nine months, 2027 results on Nov 04, 2027お知らせ • Nov 07+ 1 more updateIMCD N.V. to Report First Half, 2026 Results on Jul 29, 2026IMCD N.V. announced that they will report first half, 2026 results on Jul 29, 2026お知らせ • Aug 01+ 2 more updatesIMCD N.V. to Report Q1, 2026 Results on Apr 30, 2026IMCD N.V. announced that they will report Q1, 2026 results on Apr 30, 2026お知らせ • Nov 09+ 3 more updatesIMCD N.V. to Report Q1, 2025 Results on Apr 25, 2025IMCD N.V. announced that they will report Q1, 2025 results on Apr 25, 2025お知らせ • Aug 05+ 2 more updatesIMCD N.V. to Report Q1, 2024 Results on Apr 26, 2024IMCD N.V. announced that they will report Q1, 2024 results on Apr 26, 2024すべての更新を表示Recent updatesお知らせ • May 06IMCD N.V. to Report Q1, 2027 Results on Apr 29, 2027IMCD N.V. announced that they will report Q1, 2027 results on Apr 29, 2027お知らせ • May 03IMCD N.V. Approves Cash Dividend, Payable on 8 May 2026IMCD N.V., at the AGM held on April 30, 2026 approved cash dividend of EUR 1.81 per share. Ex-dividend date is 5 May 2026. Dividend record date is 6 May 2026. Dividend payment date is 8 May 2026.お知らせ • Apr 17+ 3 more updatesIMCD N.V. to Report Nine Months, 2027 Results on Nov 04, 2027IMCD N.V. announced that they will report nine months, 2027 results on Nov 04, 2027お知らせ • Feb 21IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Willows Ingredients Group Limited.IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Willows Ingredients Group Limited on February 20, 2026. Through the integration of Willows Ingredients’ supplier partnerships, IMCD will broaden its portfolio and market access to customers throughout Ireland and the UK. The transaction is subject to customary closing conditions and is expected to close in the first quarter of 2026.お知らせ • Feb 18IMCD N.V. Proposes Dividend for the Year 2025IMCD N.V. proposed dividend of EUR 1.81 in cash per share (2024: EUR 2.15) for the year 2025.お知らせ • Dec 13IMCD N.V. Announces Chief Financial Officer ChangesIMCD N.V. announced that its Supervisory Board nominates Floris Lagerwerf to become Chief Financial Officer (CFO) of IMCD as of January 2027. Floris will succeed Hans Kooijmans, who has decided to retire as per the end of December 2026. Floris started his career as external auditor in 2006, and he joined IMCD in its Rotterdam headquarters in 2016 as Group Controller. In 2021 he became Finance & Operations Director at IMCD Switzerland, and since January 2023, serves as Vice-President Finance & Operations for the Americas region. As of January 1, 2026, Floris will be Vice-President Finance & Operations EMEA and Industrial Business Groups. Hans Kooijmans will remain CFO of IMCD until the end of 2026 and will support Floris towards the transition in 2027.お知らせ • Nov 07+ 1 more updateIMCD N.V. to Report First Half, 2026 Results on Jul 29, 2026IMCD N.V. announced that they will report first half, 2026 results on Jul 29, 2026お知らせ • Oct 17IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Dong Yang FT Corp.IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Dong Yang FT Corp. on October 16, 2025. For the period ending December 31, 2024, Dong Yang FT Corp. reported total revenue of KRW 55.3 billion. The transaction is subject to customary (regulatory) closing conditions and is expected to close in the first quarter of 2026.お知らせ • Aug 27IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Tillmanns Spa.IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Tillmanns Spa on August 27, 2025. In 2024, Tillmanns reported annual revenues of ca. €143 million. The transaction is subject to customary (regulatory) closing conditions and is expected to close in the fourth quarter of 2025. Domenico Colella and Pietro Masi of Orsingher Ortu Avvocati Associati acted as legal advisor for IMCD N.V. (ENXTAM:IMCD). Ethica Holding S.p.A. acted as financial advisor for the shareholders of Tillmanns Spa. Massimo Di Terlizzi, Graziana Toscano, Giorgio Recine, and Costanza Ceruti of Studio Pirola Pennuto Zei & Associati acted as legal advisor for the shareholders of Tillmanns Spa. For strategic and tax matters, Tillmanns and its partner were supported by Stefano Cesati of Studio Pirola Pennuto Zei & Associati.お知らせ • Aug 01+ 2 more updatesIMCD N.V. to Report Q1, 2026 Results on Apr 30, 2026IMCD N.V. announced that they will report Q1, 2026 results on Apr 30, 2026お知らせ • Jul 31IMCD N.V., Annual General Meeting, Apr 30, 2026IMCD N.V., Annual General Meeting, Apr 30, 2026.お知らせ • Jun 30IMCD N.V. (ENXTAM:IMCD) agreed to acquire Apus Química SpA.IMCD N.V. (ENXTAM:IMCD) agreed to acquire Apus Química SpA on June 30, 2025. The terms of the transaction are undisclosed. For the period ending December 31, 2024, Apus Química SpA reported total revenue of approximately €15 million. The transaction is subject to customary closing conditions and is expected to close in July 2025.お知らせ • Jun 06IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Ferrer Alimentacion Sa.IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Ferrer Alimentacion Sa on June 6, 2025. For the period ending December 31, 2024, Ferrer Alimentacion Sa reported total revenue of €112 million. The transaction is subject to customary closing conditions and is expected to close in June 2025.お知らせ • Mar 06IMCD N.V. announces Annual dividend, payable on May 06, 2025IMCD N.V. announced Annual dividend of EUR 2.1500 per share payable on May 06, 2025, ex-date on April 29, 2025 and record date on April 30, 2025.お知らせ • Nov 14IMCD N.V. has filed a Follow-on Equity Offering in the amount of €300 million.IMCD N.V. has filed a Follow-on Equity Offering in the amount of €300 million. Security Name: Ordinary Shares Security Type: Common Stockお知らせ • Nov 09+ 3 more updatesIMCD N.V. to Report Q1, 2025 Results on Apr 25, 2025IMCD N.V. announced that they will report Q1, 2025 results on Apr 25, 2025お知らせ • Oct 17IMCD N.V. (ENXTAM:IMCD) agreed to acquire Blumos Group.IMCD N.V. (ENXTAM:IMCD) has signed an agreement to acquire Blumos Group on October 17, 2024. The transaction is subject to customary regulatory closing conditions. The expected completion of the transaction is in the fourth quarter of 2024.お知らせ • Aug 03IMCD N.V., Annual General Meeting, Apr 25, 2025IMCD N.V., Annual General Meeting, Apr 25, 2025.お知らせ • May 16IMCD N.V. Approves Dividend for the Year 2023, Payable on 21 May 2024IMCD N.V. announced that at its AGM held on May 14, 2024, approved the dividend proposal of EUR 2.24 per share in cash. Ex-dividend date is on 16 May 2024. Dividend record date is on 17 May 2024. Dividend payment date is on 21 May 2024.お知らせ • Jan 10IMCD N.V. (ENXTAM:IMCD) acquired 70% stake in Valuetree Ingredients Private Limited from the founders of Valuetree Ingredients Private Limited.IMCD N.V. (ENXTAM:IMCD) acquired 70% stake in Valuetree Ingredients Private Limited from the founders of Valuetree Ingredients Private Limited on January 10, 2024. IMCD N.V. (ENXTAM:IMCD) will acquire the remaining 30% stake in Valuetree Ingredients Private Limited in 2025. The founders of Valuetree will continue to lead the company post-completion of this first tranche. For the financial year ended on March 31, 2023 Valuetree Ingredients Private Limited generated revenue of approximately INR 4.4 billion. IMCD N.V. (ENXTAM:IMCD) completed the acquisition of 70% stake in Valuetree Ingredients Private Limited from the founders of Valuetree Ingredients Private Limited on January 10, 2024.お知らせ • Nov 30IMCD Appoints Dorthe Mikkelsen as Member of the Supervisory BoardIMCD N.V. announced that Mrs. Dorthe Mikkelsen has been appointed as member of the Supervisory Board at the Extraordinary General Meeting of IMCD N.V. held on 27 November 2023.お知らせ • Aug 05+ 2 more updatesIMCD N.V. to Report Q1, 2024 Results on Apr 26, 2024IMCD N.V. announced that they will report Q1, 2024 results on Apr 26, 2024お知らせ • Aug 02IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Sachs Chemical, Inc.IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Sachs Chemical, Inc. on August 1, 2023. Sachs Chemical, Inc. generated a revenue of approximately $50 million in 2022. IMCD welcomes Sachs’ 38 employees to its local organization. The closing of the transaction is subject to customary closing conditions and is expected to take place in August 2023.お知らせ • Jun 17IMCD N.V. (ENXTAM:IMCD) agreed to acquire Brylchem Group.IMCD N.V. (ENXTAM:IMCD) agreed to acquire Brylchem Group on June 16, 2023. IMCD will acquire Brylchem Pte Ltd, Chemipac Pte Ltd, and CMS Marketing Trading Co., Ltd. Brylchem Group achieved a revenue of approximately SGD 85 million in 2022. The transaction is expected to be completed in the fourth quarter of 2023, subject to customary closing conditions.New Risk • Jun 08New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 1.7% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks High level of debt (56% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.お知らせ • May 19IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Euro Chemo-Pharma Sdn. Bhd.IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Euro Chemo-Pharma Sdn. Bhd. on May 19, 2023. In this transaction, IMCD will also acquire Euro Chemo-Pharma's wholly owned subsidiary, Biofresh Green Sdn Bhd. Euro Chemo-Pharma has reported revenue of approximately MYR 270 million during financial year ended on June 30, 2022. The closing of the transaction is subject to customary closing conditions. The transaction is expected to take place in the last quarter of 2023.お知らせ • May 06IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Koi Products Solutions & Engineering Ltd.IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Koi Products Solutions & Engineering Ltd on May 5, 2023. KOI Products has generated a revenue of above €8 million in financial year 2022 and adds 13 employees to the IMCD Israel team. The closing of the transaction is subject to customary closing conditions and is expected to take place in June 2023.お知らせ • Feb 17IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire CPS Chemical Oil-Tech (Pty) Ltd.IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire CPS Chemical Oil-Tech (Pty) Ltd on February 16, 2023. CPS Oil-Tech generated a revenue of approximately ZAR 228 million in the financial year that ended on February 28, 2022. The company represents leading global suppliers and serves a large group of customers with an extensive portfolio of products alongside commercial and technical support. Joining forces with CPS Oil-Tech will enable IMCD South Africa to offer its customers an increased product offering, through the valued strategic principals that CPS Oil-Tech, already represents. The closing of the transaction is subject to customary closing conditions and regulatory approval and is expected to take place in the second quarter of 2023.お知らせ • Oct 11IMCD N.V. to Report First Half, 2023 Results on Aug 04, 2023IMCD N.V. announced that they will report first half, 2023 results on Aug 04, 2023お知らせ • Aug 04+ 1 more updateIMCD N.V. to Report Q1, 2023 Results on Apr 26, 2023IMCD N.V. announced that they will report Q1, 2023 results on Apr 26, 2023収支内訳IMCD の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:IMCD.Y 収益、費用、利益 ( )EUR Millions日付収益収益G+A経費研究開発費31 Dec 254,805218568030 Sep 254,822242566030 Jun 254,839267563031 Mar 254,793272551031 Dec 244,747278539030 Sep 244,653280527030 Jun 244,559281514031 Mar 244,511287503031 Dec 234,463292491030 Sep 234,527290490030 Jun 234,590289489031 Mar 234,606301486031 Dec 224,622313483030 Sep 224,357296460030 Jun 224,091279436031 Mar 223,772243412031 Dec 213,453207387030 Sep 213,257184370030 Jun 213,060162353031 Mar 212,924141342031 Dec 202,787120332030 Sep 202,752114324030 Jun 202,717108316031 Mar 202,711108308031 Dec 192,705108300030 Sep 192,670109295030 Jun 192,636111290031 Mar 192,512105277031 Dec 182,389100264030 Sep 182,26094250030 Jun 182,13188235031 Mar 182,02283222031 Dec 171,91277209030 Sep 171,84077200030 Jun 171,76876191031 Mar 171,74375187031 Dec 161,71873183030 Sep 161,70671179030 Jun 161,69369175031 Mar 161,61565169031 Dec 151,53762163030 Sep 151,46557155030 Jun 151,392531480質の高い収益: IMCD.Yは 高品質の収益 を持っています。利益率の向上: IMCD.Yの現在の純利益率 (4.5%)は、昨年(5.9%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: IMCD.Yの収益は過去 5 年間で年間8.1%増加しました。成長の加速: IMCD.Yは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: IMCD.Yは過去 1 年間で収益成長率がマイナス ( -21.8% ) となったため、 Trade Distributors業界平均 ( 3.9% ) と比較することが困難です。株主資本利益率高いROE: IMCD.Yの 自己資本利益率 ( 10.7% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YCapital-goods 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/15 10:19終値2026/05/15 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋IMCD N.V. 12 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。23 アナリスト機関Gaurav JainBarclaysJames StewartBarclaysAnil ShenoyBarclays20 その他のアナリストを表示
お知らせ • May 06IMCD N.V. to Report Q1, 2027 Results on Apr 29, 2027IMCD N.V. announced that they will report Q1, 2027 results on Apr 29, 2027
お知らせ • Apr 17+ 3 more updatesIMCD N.V. to Report Nine Months, 2027 Results on Nov 04, 2027IMCD N.V. announced that they will report nine months, 2027 results on Nov 04, 2027
お知らせ • Nov 07+ 1 more updateIMCD N.V. to Report First Half, 2026 Results on Jul 29, 2026IMCD N.V. announced that they will report first half, 2026 results on Jul 29, 2026
お知らせ • Aug 01+ 2 more updatesIMCD N.V. to Report Q1, 2026 Results on Apr 30, 2026IMCD N.V. announced that they will report Q1, 2026 results on Apr 30, 2026
お知らせ • Nov 09+ 3 more updatesIMCD N.V. to Report Q1, 2025 Results on Apr 25, 2025IMCD N.V. announced that they will report Q1, 2025 results on Apr 25, 2025
お知らせ • Aug 05+ 2 more updatesIMCD N.V. to Report Q1, 2024 Results on Apr 26, 2024IMCD N.V. announced that they will report Q1, 2024 results on Apr 26, 2024
お知らせ • May 06IMCD N.V. to Report Q1, 2027 Results on Apr 29, 2027IMCD N.V. announced that they will report Q1, 2027 results on Apr 29, 2027
お知らせ • May 03IMCD N.V. Approves Cash Dividend, Payable on 8 May 2026IMCD N.V., at the AGM held on April 30, 2026 approved cash dividend of EUR 1.81 per share. Ex-dividend date is 5 May 2026. Dividend record date is 6 May 2026. Dividend payment date is 8 May 2026.
お知らせ • Apr 17+ 3 more updatesIMCD N.V. to Report Nine Months, 2027 Results on Nov 04, 2027IMCD N.V. announced that they will report nine months, 2027 results on Nov 04, 2027
お知らせ • Feb 21IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Willows Ingredients Group Limited.IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Willows Ingredients Group Limited on February 20, 2026. Through the integration of Willows Ingredients’ supplier partnerships, IMCD will broaden its portfolio and market access to customers throughout Ireland and the UK. The transaction is subject to customary closing conditions and is expected to close in the first quarter of 2026.
お知らせ • Feb 18IMCD N.V. Proposes Dividend for the Year 2025IMCD N.V. proposed dividend of EUR 1.81 in cash per share (2024: EUR 2.15) for the year 2025.
お知らせ • Dec 13IMCD N.V. Announces Chief Financial Officer ChangesIMCD N.V. announced that its Supervisory Board nominates Floris Lagerwerf to become Chief Financial Officer (CFO) of IMCD as of January 2027. Floris will succeed Hans Kooijmans, who has decided to retire as per the end of December 2026. Floris started his career as external auditor in 2006, and he joined IMCD in its Rotterdam headquarters in 2016 as Group Controller. In 2021 he became Finance & Operations Director at IMCD Switzerland, and since January 2023, serves as Vice-President Finance & Operations for the Americas region. As of January 1, 2026, Floris will be Vice-President Finance & Operations EMEA and Industrial Business Groups. Hans Kooijmans will remain CFO of IMCD until the end of 2026 and will support Floris towards the transition in 2027.
お知らせ • Nov 07+ 1 more updateIMCD N.V. to Report First Half, 2026 Results on Jul 29, 2026IMCD N.V. announced that they will report first half, 2026 results on Jul 29, 2026
お知らせ • Oct 17IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Dong Yang FT Corp.IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Dong Yang FT Corp. on October 16, 2025. For the period ending December 31, 2024, Dong Yang FT Corp. reported total revenue of KRW 55.3 billion. The transaction is subject to customary (regulatory) closing conditions and is expected to close in the first quarter of 2026.
お知らせ • Aug 27IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Tillmanns Spa.IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Tillmanns Spa on August 27, 2025. In 2024, Tillmanns reported annual revenues of ca. €143 million. The transaction is subject to customary (regulatory) closing conditions and is expected to close in the fourth quarter of 2025. Domenico Colella and Pietro Masi of Orsingher Ortu Avvocati Associati acted as legal advisor for IMCD N.V. (ENXTAM:IMCD). Ethica Holding S.p.A. acted as financial advisor for the shareholders of Tillmanns Spa. Massimo Di Terlizzi, Graziana Toscano, Giorgio Recine, and Costanza Ceruti of Studio Pirola Pennuto Zei & Associati acted as legal advisor for the shareholders of Tillmanns Spa. For strategic and tax matters, Tillmanns and its partner were supported by Stefano Cesati of Studio Pirola Pennuto Zei & Associati.
お知らせ • Aug 01+ 2 more updatesIMCD N.V. to Report Q1, 2026 Results on Apr 30, 2026IMCD N.V. announced that they will report Q1, 2026 results on Apr 30, 2026
お知らせ • Jul 31IMCD N.V., Annual General Meeting, Apr 30, 2026IMCD N.V., Annual General Meeting, Apr 30, 2026.
お知らせ • Jun 30IMCD N.V. (ENXTAM:IMCD) agreed to acquire Apus Química SpA.IMCD N.V. (ENXTAM:IMCD) agreed to acquire Apus Química SpA on June 30, 2025. The terms of the transaction are undisclosed. For the period ending December 31, 2024, Apus Química SpA reported total revenue of approximately €15 million. The transaction is subject to customary closing conditions and is expected to close in July 2025.
お知らせ • Jun 06IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Ferrer Alimentacion Sa.IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Ferrer Alimentacion Sa on June 6, 2025. For the period ending December 31, 2024, Ferrer Alimentacion Sa reported total revenue of €112 million. The transaction is subject to customary closing conditions and is expected to close in June 2025.
お知らせ • Mar 06IMCD N.V. announces Annual dividend, payable on May 06, 2025IMCD N.V. announced Annual dividend of EUR 2.1500 per share payable on May 06, 2025, ex-date on April 29, 2025 and record date on April 30, 2025.
お知らせ • Nov 14IMCD N.V. has filed a Follow-on Equity Offering in the amount of €300 million.IMCD N.V. has filed a Follow-on Equity Offering in the amount of €300 million. Security Name: Ordinary Shares Security Type: Common Stock
お知らせ • Nov 09+ 3 more updatesIMCD N.V. to Report Q1, 2025 Results on Apr 25, 2025IMCD N.V. announced that they will report Q1, 2025 results on Apr 25, 2025
お知らせ • Oct 17IMCD N.V. (ENXTAM:IMCD) agreed to acquire Blumos Group.IMCD N.V. (ENXTAM:IMCD) has signed an agreement to acquire Blumos Group on October 17, 2024. The transaction is subject to customary regulatory closing conditions. The expected completion of the transaction is in the fourth quarter of 2024.
お知らせ • Aug 03IMCD N.V., Annual General Meeting, Apr 25, 2025IMCD N.V., Annual General Meeting, Apr 25, 2025.
お知らせ • May 16IMCD N.V. Approves Dividend for the Year 2023, Payable on 21 May 2024IMCD N.V. announced that at its AGM held on May 14, 2024, approved the dividend proposal of EUR 2.24 per share in cash. Ex-dividend date is on 16 May 2024. Dividend record date is on 17 May 2024. Dividend payment date is on 21 May 2024.
お知らせ • Jan 10IMCD N.V. (ENXTAM:IMCD) acquired 70% stake in Valuetree Ingredients Private Limited from the founders of Valuetree Ingredients Private Limited.IMCD N.V. (ENXTAM:IMCD) acquired 70% stake in Valuetree Ingredients Private Limited from the founders of Valuetree Ingredients Private Limited on January 10, 2024. IMCD N.V. (ENXTAM:IMCD) will acquire the remaining 30% stake in Valuetree Ingredients Private Limited in 2025. The founders of Valuetree will continue to lead the company post-completion of this first tranche. For the financial year ended on March 31, 2023 Valuetree Ingredients Private Limited generated revenue of approximately INR 4.4 billion. IMCD N.V. (ENXTAM:IMCD) completed the acquisition of 70% stake in Valuetree Ingredients Private Limited from the founders of Valuetree Ingredients Private Limited on January 10, 2024.
お知らせ • Nov 30IMCD Appoints Dorthe Mikkelsen as Member of the Supervisory BoardIMCD N.V. announced that Mrs. Dorthe Mikkelsen has been appointed as member of the Supervisory Board at the Extraordinary General Meeting of IMCD N.V. held on 27 November 2023.
お知らせ • Aug 05+ 2 more updatesIMCD N.V. to Report Q1, 2024 Results on Apr 26, 2024IMCD N.V. announced that they will report Q1, 2024 results on Apr 26, 2024
お知らせ • Aug 02IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Sachs Chemical, Inc.IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Sachs Chemical, Inc. on August 1, 2023. Sachs Chemical, Inc. generated a revenue of approximately $50 million in 2022. IMCD welcomes Sachs’ 38 employees to its local organization. The closing of the transaction is subject to customary closing conditions and is expected to take place in August 2023.
お知らせ • Jun 17IMCD N.V. (ENXTAM:IMCD) agreed to acquire Brylchem Group.IMCD N.V. (ENXTAM:IMCD) agreed to acquire Brylchem Group on June 16, 2023. IMCD will acquire Brylchem Pte Ltd, Chemipac Pte Ltd, and CMS Marketing Trading Co., Ltd. Brylchem Group achieved a revenue of approximately SGD 85 million in 2022. The transaction is expected to be completed in the fourth quarter of 2023, subject to customary closing conditions.
New Risk • Jun 08New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 1.7% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks High level of debt (56% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
お知らせ • May 19IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Euro Chemo-Pharma Sdn. Bhd.IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Euro Chemo-Pharma Sdn. Bhd. on May 19, 2023. In this transaction, IMCD will also acquire Euro Chemo-Pharma's wholly owned subsidiary, Biofresh Green Sdn Bhd. Euro Chemo-Pharma has reported revenue of approximately MYR 270 million during financial year ended on June 30, 2022. The closing of the transaction is subject to customary closing conditions. The transaction is expected to take place in the last quarter of 2023.
お知らせ • May 06IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Koi Products Solutions & Engineering Ltd.IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Koi Products Solutions & Engineering Ltd on May 5, 2023. KOI Products has generated a revenue of above €8 million in financial year 2022 and adds 13 employees to the IMCD Israel team. The closing of the transaction is subject to customary closing conditions and is expected to take place in June 2023.
お知らせ • Feb 17IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire CPS Chemical Oil-Tech (Pty) Ltd.IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire CPS Chemical Oil-Tech (Pty) Ltd on February 16, 2023. CPS Oil-Tech generated a revenue of approximately ZAR 228 million in the financial year that ended on February 28, 2022. The company represents leading global suppliers and serves a large group of customers with an extensive portfolio of products alongside commercial and technical support. Joining forces with CPS Oil-Tech will enable IMCD South Africa to offer its customers an increased product offering, through the valued strategic principals that CPS Oil-Tech, already represents. The closing of the transaction is subject to customary closing conditions and regulatory approval and is expected to take place in the second quarter of 2023.
お知らせ • Oct 11IMCD N.V. to Report First Half, 2023 Results on Aug 04, 2023IMCD N.V. announced that they will report first half, 2023 results on Aug 04, 2023
お知らせ • Aug 04+ 1 more updateIMCD N.V. to Report Q1, 2023 Results on Apr 26, 2023IMCD N.V. announced that they will report Q1, 2023 results on Apr 26, 2023